From Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio:

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia—

1994
Stacy Howard

Blast crisis of chronic myelogenous leukemia (CML).

Peripheral blood smear revealing the histopathologic features indicative of a Blast crisis in the case of chronic myelogenous leukemia, image by Stacy Howard of the CDC: https://phil.cdc.gov/phil/details.asp

Underwriters and Partners

Xpertise: Watch + Learn

Xconomy Insight · Special Report
Starting a Biotech Company: What Every Entrepreneur Needs to Know
Get advice from the experts to help your biotech startup succeed

Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

From Our Advertisers

Wisconsin helps biotech company raise $20 million
See how TAI Diagnostics achieved accelerated growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy